ARCHIVES

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

This article is from The Cancer Letter archive.

Vol. 08 No. 23 | June 4, 1982

Download PDF Visit The Full Archive

Related Articles

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

Cancer Panel Urges Improved Funding For Basic Science

June 16, 1995

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977